NCM · Biotechnology

Ainos, Inc. (AIMD) Stock

$1.21 +0.00% NCM: AIMD Healthcare

Valuation

MetricValue
Price$1.21
Market Cap$8.91M
P/E Ratio-0.54
P/B Ratio3.03
P/S Ratio732.66
EPS (TTM)$-3.46
52-Week High$4.44
52-Week Low$1.20
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-217.50%
ROA-73.89%
ROCE-419.14%
Gross Margin-262.97%
Operating Margin-723.93%
Net Margin-769.96%
Debt/Equity4.21
Current Ratio1.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$4.0M$0$0$0
Operating Profit$-4.0M$-14.0M$-13.0M$-14.0M$-14.0M
Net Profit$-4.0M$-14.0M$-14.0M$-15.0M$-15.0M
EPS$-2.59$-5.14$-3.36$-1.56$-3.46
Op Margin-650.5%-397.1%-10815.0%-66772.2%-11268.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$41.0M$37.0M$32.0M$29.0M$21.0M
Total Liabilities$31.0M$2.0M$7.0M$13.0M$13.0M
Cash$2.0M$2.0M$2.0M$4.0M$0
Borrowings$4.0M$1.0M$6.0M$12.0M$11.0M

Latest News

Ainos Expands Smell AI With Growing Real-World Scent Dataset for Physical AI ACCESS Newswire · Jul 21, 2026 Interview with Jack Lu, Head of Corporate Development of Ainos, Inc. Zacks Small Cap Research · Jun 29, 2026 VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence ACCESS Newswire · Jun 22, 2026 RedChip's Future Tech Investor Conference Replays Now Available ACCESS Newswire · Jun 17, 2026 Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program ACCESS Newswire · Jun 17, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$-3.0M$-5.0M$-6.0M$-5.0M
Investing Cash Flow$0$-1.0M$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$2.0M$0$0$2.0M$-3.0M
Free Cash Flow$-1.0M$-4.0M$-5.0M$-6.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-2.50
FCF Yield-45.11%
Quick Ratio0.12
Interest Coverage-18.84
Return 1Y-33.22%
Return 3Y-92.72%
Return 5Y-99.46%

Ownership

Insiders Held61.81%
Institutions Held1.56%
Institutions Float Held4.08%
Institutional HolderSharesReport Date
Geode Capital Management, LLC53,0742026-03-31
Mariner, LLC30,8002026-03-31
Vanguard Fiduciary Trust Co14,1692026-03-31
Keystone Financial Group14,5502026-03-31
Vanguard Capital Management LLC9,2812026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADTX $0.01 -77.22% -0.01 $318 0.00%
ANLAdlai Nortye Ltd. $13.26 +2.00% -8.19 $703.84M 0.00%
ATHAAthira Pharma, Inc. $6.75 -6.12% -0.28 $26.62M 0.00%
BLRXBioLineRx Ltd. $2.85 -2.45% -1.36 $12.39M 0.00%
DAREDare Bioscience, Inc. $0.77 +0.16% -0.98 $11.59M 0.00%

About Ainos, Inc.

Ainos, Inc. is led by CEO Chun-Hsien Tsai, employs 44 people, headquartered in US, publicly traded since 2021.

Ainos, Inc. (AIMD) stock trades at $1.21 with a market capitalization of $8.91M. The stock is valued at a price-to-earnings (P/E) ratio of -0.54, price-to-book of 3.03, price-to-sales of 732.66. Over the past 52 weeks the stock has ranged between $1.20 and $4.44, and currently trades 72.7% below its 52-week high.

On profitability, Ainos, Inc. generates a return on equity (ROE) of -217.50%, return on capital employed of -419.14%, an operating margin of -723.93%, a net profit margin of -769.96%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides